1. Apoptosis Induced by ESC-3 Through Notch Signaling Pathway and Mitochondrial Membrane Potential (ΔΨm) in Liver Cancer.
- Author
-
Qirui Fu, Shaomin Huang, Huan Yu, Jinkun Zeng, Qingxi Chen, Jiangxing Zhuang, and Qionghua Chen
- Subjects
- *
LIVER cancer , *CANCER treatment , *NOTCH signaling pathway , *MEMBRANE potential , *XENOGRAFTS - Abstract
MTT assay was applied to evaluate the effects of ESC-3 on the proliferation of liver cancer cells and human normal liver cancer cells (L02). Flow cytometry assays were performed to explore the distribution of the cell cycle. Western blot analysis, qPCR assay and immunohistochemistry (IHC) were performed to determine the expression levels of apoptosis-related or pathway-related protein isolated from cells and tumors. Xenograft models were employed to confirm the efficient of ESC-3 on inhibiting the growth of liver tumors furtherly. Significant inhibitory effects of ESC-3 were observed in liver cancer, while there is no remarkable change in the proliferation of human normal liver cancer cells after treatment with ESC-3 compared with control group. Our findings elucidated that ESC-3 might cause S-phase cycle arrest through cyclinA1 and CDK2. In addition, we demonstrated that apoptosis induced by ESC-3 was closely contacted with Notch signaling pathway and mitochondrial membrane potential (ΔΨm) in liver cancer. Importantly, ESC-3 could markedly inhibit the growth of transplantation tumors without toxic to BALB/c nude mice in xenograft models. Our study elucidated that ESC-3 could induce apoptosis through Notch signaling pathway and mitochondrial membrane potential (ΔΨm), therefore ESC-3 could be a potential therapeutic in liver cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2019